Jason A Oliver1, Lauren R Pacek2, Erin N Locey2, Laura M Fish3, Peter S Hendricks4, Kathryn I Pollak5. 1. Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, United States of America; Division of Cancer Control and Population Sciences, Duke Cancer Institute, United States of America. Electronic address: Jason.A.Oliver@duke.edu. 2. Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, United States of America. 3. Division of Cancer Control and Population Sciences, Duke Cancer Institute, United States of America; Department of Community and Family Medicine, Duke University School of Medicine, United States of America. 4. Department of Health Behavior, University of Alabama at Birmingham, United States of America. 5. Division of Cancer Control and Population Sciences, Duke Cancer Institute, United States of America; Department of Population Sciences, Duke University School of Medicine, United States of America.
Abstract
BACKGROUND: Most clinical and laboratory smoking research studies require that participants smoke at a certain level to be eligible for enrollment. However, there is limited evidence that use of these cutoffs differentiates groups of smokers along clinically meaningful criteria. METHODS: Using receiver operating characteristic curves, we analyzed data from daily smokers in the National Epidemiologic Study of Alcohol Use and Related Conditions - III (NESARC-III) to examine the utility of smoking rates for determining whether participants met DSM-5 criteria for tobacco use disorder, experienced nicotine withdrawal or had a history of failed quit attempts. We also examined whether relationships between these variables differed as a function of key sample characteristics. RESULTS: Smoking rate exhibited a weak relationship with the presence of tobacco use disorder (AUC = 0.664), whether individuals experience nicotine withdrawal (AUC = 0.672) and whether individuals had a history of failed quit attempts (AUC = 0.578). The relationship between smoking rate and a history of failed quit attempts was weaker for women than men (p < .05). Otherwise, utility did not differ as a function of sex, race/ethnicity, education, income, or use of multiple tobacco products. Optimal cutoffs varied somewhat across indices, but the largest number of correct classifications occurred at very low smoking rates. CONCLUSIONS: Researchers should consider abandoning the use of smoking rate cutoffs to determine study eligibility. If smoking rate cutoffs are used, a rationale should be presented along with justification for the specific cutoff chosen.
BACKGROUND: Most clinical and laboratory smoking research studies require that participants smoke at a certain level to be eligible for enrollment. However, there is limited evidence that use of these cutoffs differentiates groups of smokers along clinically meaningful criteria. METHODS: Using receiver operating characteristic curves, we analyzed data from daily smokers in the National Epidemiologic Study of Alcohol Use and Related Conditions - III (NESARC-III) to examine the utility of smoking rates for determining whether participants met DSM-5 criteria for tobacco use disorder, experienced nicotine withdrawal or had a history of failed quit attempts. We also examined whether relationships between these variables differed as a function of key sample characteristics. RESULTS: Smoking rate exhibited a weak relationship with the presence of tobacco use disorder (AUC = 0.664), whether individuals experience nicotine withdrawal (AUC = 0.672) and whether individuals had a history of failed quit attempts (AUC = 0.578). The relationship between smoking rate and a history of failed quit attempts was weaker for women than men (p < .05). Otherwise, utility did not differ as a function of sex, race/ethnicity, education, income, or use of multiple tobacco products. Optimal cutoffs varied somewhat across indices, but the largest number of correct classifications occurred at very low smoking rates. CONCLUSIONS: Researchers should consider abandoning the use of smoking rate cutoffs to determine study eligibility. If smoking rate cutoffs are used, a rationale should be presented along with justification for the specific cutoff chosen.
Authors: Kolawole S Okuyemi; Kari Jo Harris; Monica Scheibmeir; Won S Choi; Joshua Powell; Jasjit S Ahluwalia Journal: Nicotine Tob Res Date: 2002 Impact factor: 4.244
Authors: Lisa C Dierker; Eric Donny; Stephen Tiffany; Suzanne M Colby; Nicholas Perrine; Richard R Clayton Journal: Drug Alcohol Depend Date: 2006-07-11 Impact factor: 4.492
Authors: Ovide F Pomerleau; Cynthia S Pomerleau; Ann M Mehringer; Sandy M Snedecor; Raphaela Ninowski; Ananda Sen Journal: Nicotine Tob Res Date: 2005-02 Impact factor: 4.244
Authors: Kathryn I Pollak; Cheryl A Oncken; Isaac M Lipkus; Pauline Lyna; Geeta K Swamy; Pamela K Pletsch; Bercedis L Peterson; R Phillips Heine; Rebecca J Namenek Brouwer; Laura Fish; Evan R Myers Journal: Am J Prev Med Date: 2007-10 Impact factor: 5.043